BACKGROUND AND PURPOSE: Antithrombotic medications (anticoagulants and antiplatelets) are often withheld in the periprocedural period and after bleeding complications to limit the risk of new or recurrent bleeding. These medications are also stopped by patients for various reasons such as cost, side effects, or unwillingness to take medication. METHODS: Patient records from the population-based Greater Cincinnati/Northern Kentucky Stroke Study were reviewed to identify cases of ischemic stroke in 2005 and determine the temporal association of strokes with withdrawal of antithrombotic medication. Ischemic strokes and reasons for medication withdrawal were identified by study nurses for subsequent physician review. RESULTS: In 2005, 2197 cases of ischemic stroke among residents of the region were identified through hospital discharge records. Of the 2197 ischemic strokes, 114 (5.2%) occurred within 60 days of an antithrombotic medication withdrawal, 61 (53.5%) of these after stoppage of warfarin and the remainder after stoppage of an antiplatelet medication. Of the strokes after withdrawal, 71 (62.3%) were first-ever and 43 (37.7%) were recurrent; 54 (47.4%) occurred after withdrawal of medication by a physician in the periprocedural period. CONCLUSIONS: The withdrawal of antiplatelet and antithrombotic medications in the 60 days preceding an acute ischemic stroke was associated with 5.2% of ischemic strokes in our study population. This finding emphasizes the need for thoughtful decision-making concerning antithrombotic medication use in the periprocedural period and efforts to improve patient compliance.
BACKGROUND AND PURPOSE: Antithrombotic medications (anticoagulants and antiplatelets) are often withheld in the periprocedural period and after bleeding complications to limit the risk of new or recurrent bleeding. These medications are also stopped by patients for various reasons such as cost, side effects, or unwillingness to take medication. METHODS:Patient records from the population-based Greater Cincinnati/Northern Kentucky Stroke Study were reviewed to identify cases of ischemic stroke in 2005 and determine the temporal association of strokes with withdrawal of antithrombotic medication. Ischemic strokes and reasons for medication withdrawal were identified by study nurses for subsequent physician review. RESULTS: In 2005, 2197 cases of ischemic stroke among residents of the region were identified through hospital discharge records. Of the 2197 ischemic strokes, 114 (5.2%) occurred within 60 days of an antithrombotic medication withdrawal, 61 (53.5%) of these after stoppage of warfarin and the remainder after stoppage of an antiplatelet medication. Of the strokes after withdrawal, 71 (62.3%) were first-ever and 43 (37.7%) were recurrent; 54 (47.4%) occurred after withdrawal of medication by a physician in the periprocedural period. CONCLUSIONS: The withdrawal of antiplatelet and antithrombotic medications in the 60 days preceding an acute ischemic stroke was associated with 5.2% of ischemic strokes in our study population. This finding emphasizes the need for thoughtful decision-making concerning antithrombotic medication use in the periprocedural period and efforts to improve patient compliance.
Authors: Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano Journal: Europace Date: 2006-09 Impact factor: 5.214
Authors: Elaine M Hylek; Alan S Go; Yuchiao Chang; Nancy G Jensvold; Lori E Henault; Joe V Selby; Daniel E Singer Journal: N Engl J Med Date: 2003-09-11 Impact factor: 91.245
Authors: Brett Kissela; Alexander Schneider; Dawn Kleindorfer; Jane Khoury; Rosemary Miller; Kathleen Alwell; Daniel Woo; Jerzy Szaflarski; James Gebel; Charles Moomaw; Arthur Pancioli; Edward Jauch; Rakesh Shukla; Joseph Broderick Journal: Stroke Date: 2004-02 Impact factor: 7.914
Authors: M J Kovacs; C Kearon; M Rodger; D R Anderson; A G G Turpie; S M Bates; L Desjardins; J Douketis; S R Kahn; S Solymoss; P S Wells Journal: Circulation Date: 2004-09-13 Impact factor: 29.690
Authors: Ljiljana Bogunovic; Richard H Gelberman; Charles A Goldfarb; Martin I Boyer; Ryan P Calfee Journal: J Hand Surg Am Date: 2015-10-01 Impact factor: 2.230
Authors: Wardati Mazlan-Kepli; Rachael L Macisaac; Matthew Walters; Philip Michael William Bath; Jesse Dawson Journal: Br J Clin Pharmacol Date: 2017-04-20 Impact factor: 4.335
Authors: Ljiljana Bogunovic; Richard H Gelberman; Charles A Goldfarb; Martin I Boyer; Ryan P Calfee Journal: J Hand Surg Am Date: 2013-06 Impact factor: 2.230
Authors: Sharyl R Martini; Matthew L Flaherty; W Mark Brown; Mary Haverbusch; Mary E Comeau; Laura R Sauerbeck; Brett M Kissela; Ranjan Deka; Dawn O Kleindorfer; Charles J Moomaw; Joseph P Broderick; Carl D Langefeld; Daniel Woo Journal: Neurology Date: 2012-11-21 Impact factor: 9.910
Authors: Monica L Wagner; Jane C Khoury; Kathleen Alwell; Eric Rademacher; Daniel Woo; Matthew L Flaherty; Aaron M Anderson; Opeolu Adeoye; Simona Ferioli; Brett M Kissela; Dawn Kleindorfer; Joseph P Broderick Journal: J Stroke Cerebrovasc Dis Date: 2016-01-28 Impact factor: 2.136